BiotechTube
Data
Discover
News
Company
Search...
โK
Sign in
BiotechTube
Home
/
Retension Pharmaceuticals
/
Eric Keller
EK
Eric Keller
Chief Executive Officer, Founder & Chairman
Retension Pharmaceuticals
Therapeutic Areas
Cardiovascular
Hypertension
Retension Pharmaceuticals Pipeline
Drug
Indication
Phase
RTN-001
Uncontrolled Hypertension
Phase 2
Leadership Team at Retension Pharmaceuticals
PS
Paul Sweetnam
Chief Scientific Officer & Co-Founder
WS
William Sasiela
Chief Medical Officer
View full Retension Pharmaceuticals profile